RankingsPricing
  1. US-listed companies
  2. Salarius Pharmaceuticals, Inc.
  3. Financials
  4. Total assets

Salarius Pharmaceuticals, Inc.SLRX

Market cap
$1.53M
P/E ratio
SummaryFinancials
Period EndTotal assets (Million USD)YoY (%)
Dec 31, 20243-54.10%
Dec 31, 20237-55.04%
Dec 31, 202215-64.12%
Dec 31, 202141+63.78%
Dec 31, 202025+79.44%
Dec 31, 201914+33.73%
Dec 31, 201810-70.31%
Dec 31, 201735-44.64%
Dec 31, 201663-33.51%
Dec 31, 201595+166.96%
Dec 31, 201436

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)